Cover Image

Guidance for industry source animal, product, preclinical, and clinical issues concerning the use of xenotransplantation products in humans.

Other Authors:	Center for Biologics Evaluation and Research (U.S.)
Format:	Electronic
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2003]
Physical Description:	ii, 60 pages : digital, PDF file.
Subjects:	Xenografts -- Government policy -- United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS113066

Similar Items

Guidance for industry precautionary measures to reduce the possible risk of transmission of zoonoses by blood and blood products from xenotransplantation product recipients and their contacts
Published: (1999)

Guidance for industry precautionary measures to reduce the possible risk of transmission of zoonoses by blood and blood products from xenotransplantation product recipients and their intimate contacts
Published: (2002)

PHS guideline on infectious disease issues in xenotransplantation
Published: (2001)

Clinical xenotransplantation : pathways and progress in the transplantation of organs and tissues between species
Published: (2020)

Xenotransplantation : science, ethics, and public policy
by: Institute of Medicine (U.S.). Committee on Xenograft Transplantation: Ethical Issues and Public Policy.
Published: (1996)

Guidance for industry public health issues posed by the use of nonhuman primate xenografts in humans
Published: (1999)

Xenotransplantation : ethical, regulatory, and social aspects
Published: (2023)

Information sheet guidance for institutional review boards and clinical investigators (use of investigational products when subjects enter a second institution)
Published: (1998)

Career development programs guide
Published: (1987)

The NIH Training Center
Published: (1987)

Fact sheet I, FDA's new interim final rule prohibiting use of certain cattle materials that may carry the risk of bovine spongiform encephalopathy in human foods and cosmetics, and II, FDA's proposed rule on recordkeeping requirements for human food and cosmetics manufactured from, processed with, or otherwise containing material from cattle
Published: (2004)

Food safety current and emerging issues influencing public health and trade : U.S. food safety outreach meeting highlights, European Union, Brussels, Belgium; Warsaw, Poland; Prague, Czech Republic; Budapest, Hungary
Published: (2002)

Current issues in human subject protection : an FDA perspective : September 13, 1996, Natcher Auditorium
Published: (1996)

Sialo-xenoantigenic glycobiology : molecular glycobiology of sialylglycan-xenoantigenic determinants in pig to human xenotransplantation
by: Song, Kwon-Ho.
Published: (2013)

What you need to know about registration of food facilities
Published: (2003)

Reviewer guidance conducting a clinical safety review of a new product application and preparing a report on the review
Published: (2005)

The Health field needs you
Published: (1986)

Information sheet guidance for institutional review boards and clinical investigators (payment to research subjects)
Published: (1998)

Information sheet guidance for institutional review boards and clinical investigators (screening tests prior to study enrollment)
Published: (1998)

Information sheet guidance for institutional review boards and clinical investigators (recruiting study subjects)
Published: (1998)

Information sheet guidance for institutional review boards and clinical investigators (charging for investigational products)
Published: (1998)

Points to consider in the manufacture and testing of monoclonal antibody products for human use
Published: (1997)

Guidance for clinical investigators, sponsors, and IRBs adverse event reporting to IRBs : improving human subject protection
Published: (2009)

Guidance for industry year 2000 date change for computer systems and software applications used in the manufacture of blood products
Published: (1998)

Draft guidance for industry and FDA staff technical considerations for pen, jet, and related injectors intended for use with drugs and biological products
Published: (2009)

NIOSH recommendations for occupational safety and health compendium of policy documents and statements
by: National Institute for Occupational Safety and Health.
Published: (1992)

Guidance for industry E 10 choice of control group and related issues in clinical trials
Published: (2001)

Guidance for industry computerized systems used in clinical trials
Published: (1999)

An invitation to involvement : engineering career opportunities in the U.S. Public Health Service
by: United States. Public Health Service.
Published: (1991)

Guidance for industry providing regulatory submissions in electronic format : human pharmaceutical product applications and related submissions using the eCTD specifications
Published: (2008)

Selected topics in surface electromyography for use in the occupational setting : expert perspectives
Published: (1992)

Guidance for industry and FDA staff devices used to process human cells, tissues, and cellular and tissue-based products (HCT/Ps)
Published: (2007)

Guidance for industry patient-reported outcome measures, use in medical product development to support labeling claims
Published: (2006)

Guidance for industry efficacy studies to support marketing of fibrin sealant products manufactured for commercial use
Published: (1999)

Guidance for industry comparability protocols, protein drug products and biological products; chemistry, manufacturing, and controls information
Published: (2003)

Guidance for industry use of serological tests to reduce the risk of transmission of trypanosoma cruzi infection in whole blood and blood components for transfusion and human cells, tissues, and cellular and tissue-based products (HCT/Ps)
Published: (2009)

Information sheet guidance for institutional review boards and clinical investigators (treatment use of investigational drugs)
Published: (1998)

Guidance for industry revised recommendations for the assessment of donor suitability and blood product safety in cases of suspected severe acute respiratory syndrome (SARS) or exposure to SARS
Published: (2003)

Information sheet guidance for institutional review boards and clinical investigators ("off-label" and investigational use of marketed drugs, biologics, and medical devices)
Published: (1998)

The United States food safety system
Published: (2000)